Diagnostic performance of MRI and endoscopy for assessing complete response in rectal cancer after neoadjuvant chemoradiotherapy: a systematic review of the literature

1. Braendengen, M, Tveit, KM, Berglund, A, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008;26:3687–3694.
Google Scholar | Crossref | Medline | ISI2. Bülow, S, Harling, H, Iversen, LH, et al. Improved survival after rectal cancer in Denmark. Colorectal Dis 2010;12:e37–e42.
Google Scholar | Medline3. Bujko, K, Nowacki, MP, Nasierowska-Guttmejer, A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215–1223.
Google Scholar | Crossref | Medline4. Paun, BC, Cassie, S, MacLean, AR, et al. Postoperative complications following surgery for rectal cancer. Ann Surg 2010;251:807–818.
Google Scholar | Crossref | Medline | ISI5. Hendren, SK, O’Connor, BI, Liu, M, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242:212–223.
Google Scholar | Crossref | Medline | ISI6. Harrison, JD, Solomon, MJ, Young, JM, et al. Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. Arch Surg 2008;143:389–394.
Google Scholar | Crossref | Medline7. Gameiro, J, Fonseca, JA, Neves, M, et al. Acute kidney injury in major abdominal surgery: incidence, risk factors, pathogenesis and outcomes. Ann Intensive Care 2018;8:22.
Google Scholar | Crossref | Medline8. Engel, J, Kerr, J, Schlesinger-Raab, A, et al. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 2003;238:203–213.
Google Scholar | Crossref | Medline | ISI9. Mignanelli, ED, de Campos-Lobato, LF, Stocchi, L, et al. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Dis Colon Rectum 2010;53:251–256.
Google Scholar | Crossref | Medline10. Maas, M, Nelemans, PJ, Valentini, V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010;11:835–844.
Google Scholar | Crossref | Medline | ISI11. Habr-Gama, A, Perez, RO, Nadalin, W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004;240:711–718.
Google Scholar | Crossref | Medline | ISI12. Maas, M, Beets-Tan, RG, Lambregts, DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011;29:4633–4640.
Google Scholar | Crossref | Medline13. Beets-Tan, RG, Lambregts, DM, Maas, M, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018;28:1465–1475.
Google Scholar | Crossref | Medline14. Chen, CC, Lee, RC, Lin, JK, et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2005;48:722–728.
Google Scholar | Crossref | Medline15. Maretto, I, Pomerri, F, Pucciarelli, S, et al. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 2007;14:455–461.
Google Scholar | Crossref | Medline | ISI16. Wynn, GR, Bhasin, N, Macklin, CP, et al. Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer: opinions of British and Irish specialists. Colorectal Dis 2010;12:327–333.
Google Scholar | Crossref | Medline17. Patel, UB, Taylor, F, Blomqvist, L, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011;29:3753–3760.
Google Scholar | Crossref | Medline18. Beets-Tan, RG, Beets, GL. MRI For assessing and predicting response to neoadjuvant treatment in rectal cancer. Nat Rev Gastro Hepat 2014;11:480–488.
Google Scholar | Crossref | Medline | ISI19. Moher, D, Liberati, A, Tetzlaff, J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006–1012.
Google Scholar | Crossref | Medline | ISI20. Wille-Jørgensen, P, Renehan, AG. Systematic reviews and meta-analyses in coloproctology: interpretation and potential pitfalls. Colorectal Dis 2008;10:21–32.
Google Scholar | Medline21. Mandard, AM, Dalibard, F, Mandard, JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680–2686.
Google Scholar | Crossref | Medline | ISI22. Dworak, O, Keilholz, L, Hoffmann, A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19–23.
Google Scholar | Crossref | Medline | ISI23. Galons, JP, Lope-Piedrafita, S, Divijak, JL, et al. Uncovering of intracellular water in cultured cells. Magn Reson Med 2005;54:79–86.
Google Scholar | Crossref | Medline24. Padhani, AR, Liu, G, Mu-Koh, D, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102–125.
Google Scholar | Crossref | Medline | ISI25. Chandramohan, A, Siddiqi, UM, Mittal, R, et al. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open 2020;7:100223.
Google Scholar | Crossref | Medline26. Cho, MS, Kim, H, Han, YD, et al. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: results from a prospective study of 110 patients. Medicine (Baltimore) 2019;98:e16614.
Google Scholar | Crossref | Medline27. Jang, JK, Lee, JL, Park, SH, et al. Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer. Br J Surg 2018;105:1671–1679.
Google Scholar | Crossref | Medline28. Lee, MA, Cho, SH, Seo, AN, et al. Modified 3-point MRI-based tumor regression grade incorporating DWI for locally advanced rectal cancer. AJR Am J Roentgenol 2017;209:1247–1255.
Google Scholar | Crossref | Medline29. Sclafani, F, Brown, G, Cunningham, D, et al. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer 2017;117:1478–1485.
Google Scholar | Crossref | Medline30. Van Den Broek, JJ, Van Der Wolf, FS, Lahaye, MJ, et al. Accuracy of MRI in restaging locally advanced rectal cancer after preoperative chemoradiation. Dis Colon Rectum 2017;60:274–283.
Google Scholar | Crossref | Medline31. Rengo, M, Picchia, S, Marzi, S, et al. Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. Oncotarget 2017;8:114746–114755.
Google Scholar | Crossref | Medline32. Yu, J, Xu, Q, Song, JC, et al. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 2017;27:1848–1857.
Google Scholar | Crossref | Medline33. Bhoday, J, Smith, F, Siddiqui, MR, et al. Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy. Dis Colon Rectum 2016;59:925–933.
Google Scholar | Crossref | Medline34. Fayaz, MS, Demian, GA, Fathallah, WM, et al. Significance of magnetic resonance imaging-assessed tumor response for locally advanced rectal cancer treated with preoperative long-course chemoradiation. J Glob Oncol 2016;2:216–221.
Google Scholar | Crossref | Medline35. Patel, UB, Brown, G, Rutten, H, et al. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol 2012;19:2842–2852.
Google Scholar | Crossref | Medline36. Ko, HM, Choi, YH, Lee, JE, et al. Combination assessment of clinical complete response of patients with rectal cancer following chemoradiotherapy with endoscopy and magnetic resonance imaging. Ann Coloproctol 2019;35:202–208.
Google Scholar | Crossref | Medline37. Santiago, I, Barata, M, Figueiredo, N, et al. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer. Eur Radiol 2020;30:224–238.
Google Scholar | Crossref | Medline38. Jia, X, Zhang, Y, Wang, Y, et al. MRI For restaging locally advanced rectal cancer: detailed analysis of discrepancies with the pathologic reference standard. AJR Am J Roentgenol 2019;213:1081–1090.
Google Scholar | Crossref | Medline39. Meng, Y, Wan, L, Zhang, C, et al. The predictive value of pre-/postneoadjuvant chemoradiotherapy MRI characteristics for patient outcomes in locally advanced rectal cancer. Acad Radiol 2020;27:e233–e243.
Google Scholar | Crossref | Medline40. Nahas, SC, Nahas, CSR, Cama, GM, et al. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer. Abdom Radiol (New York) 2019;44:3632–3640.
Google Scholar | Crossref | Medline41. Wan, L, Zhang, C, Zhao, Q, et al. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Abdom Radiol (New York) 2019;44:2978–2987.
Google Scholar | Crossref | Medline42. Yoen, H, Park, HE, Kim, SH, et al. Prognostic value of tumor regression grade on MR in rectal rancer: a large-scale, single-center experience. Korean J Radiol 2020;21:1065–1076.
Google Scholar | Crossref | Medline43. Aker, M, Boone, D, Chandramohan, A, et al. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment. Abdom Radiol (New York) 2018;43:3213–3219.
Google Scholar | Crossref | Medline44. Bayram, I, Bakir, B, Kartal, MG, et al. The role of MRI with diffusion-weighted imaging in restaging rectal cancers after neoadjuvant chemoradiotherapy. South African J Radiol 2016;20:1–6.
Google Scholar | Crossref45. Choi, MH, Oh, SN, Rha, SE, et al. Diffusion-weighted imaging: apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer. J Magn Reson Imaging 2016;44:212–220.
Google Scholar | Crossref | Medline46. Foti, PV, Privitera, G, Piana, S, et al. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy. Eur J Radiol Open 2016;3:145–152.
Google Scholar | Crossref |

留言 (0)

沒有登入
gif